Neogen Stock Today
| NEOG Stock | USD 11.56 0.04 0.34% |
Performance0 of 100
| Odds Of DistressLess than 30
|
Neogen is trading at 11.56 as of the 17th of January 2025. This is a 0.34% down since the beginning of the trading day. The stock's lowest day price was 11.35. Neogen has about a 30 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Note, on July 1, 2019, Representative Greg Gianforte of US Congress acquired $100k to $250k worth of Neogen's common stock.
Business Domain Health Care Equipment & Services | IPO Date 23rd of August 1989 | Category Healthcare | Classification Health Care |
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. Neogen Cp operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 216.94 M outstanding shares of which 22.11 M shares are now shorted by private and institutional investors with about 11.82 trading days to cover. More on Neogen
Moving together with Neogen Stock
Moving against Neogen Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Neogen Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO President | John Adent | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, SP Midcap 400, NASDAQ Composite Total, NASDAQ Health Care, Health Management, Management, Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsNeogen can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Neogen's financial leverage. It provides some insight into what part of Neogen's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Neogen (NEOG) is traded on NASDAQ Exchange in USA. It is located in 620 Lesher Place, Lansing, MI, United States, 48912-1595 and employs 2,917 people. Neogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.52 B. Neogen conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 216.94 M outstanding shares of which 22.11 M shares are now shorted by private and institutional investors with about 11.82 trading days to cover.
Neogen currently holds about 347.71 M in cash with 35.26 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22.
Check Neogen Probability Of Bankruptcy
Ownership AllocationThe majority of Neogen outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Neogen to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Neogen. Please pay attention to any change in the institutional holdings of Neogen as this could imply that something significant has changed or is about to change at the company. On July 1, 2019, Representative Greg Gianforte of US Congress acquired $100k to $250k worth of Neogen's common stock.
Check Neogen Ownership Details
Neogen Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Dimensional Fund Advisors, Inc. | 2024-09-30 | 5.6 M | |
| T. Rowe Price Investment Management,inc. | 2024-09-30 | 5.6 M | |
| Geode Capital Management, Llc | 2024-09-30 | 5.1 M | |
| King Luther Capital Management Corp | 2024-09-30 | 5.1 M | |
| Morgan Stanley - Brokerage Accounts | 2024-09-30 | 4.7 M | |
| Fred Alger Management, Llc | 2024-09-30 | 4 M | |
| Blair William & Co | 2024-09-30 | 3.8 M | |
| Northern Trust Corp | 2024-09-30 | 3.6 M | |
| Hhg Plc | 2024-09-30 | 3.6 M | |
| Blackrock Inc | 2024-09-30 | 25.5 M | |
| Vanguard Group Inc | 2024-09-30 | 19.7 M |
Neogen Historical Income Statement
Neogen Stock Against Markets
Neogen Corporate Management
| John Moylan | Corporate VP | Profile | |
| Bill Waelke | Head Relations | Profile | |
| Julie Mann | VP Officer | Profile | |
| Amy Rocklin | Chief Secretary | Profile | |
| David Naemura | Chief Officer | Profile | |
| Sarah Demey | Administrative Manager | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.86) | Earnings Share (2.19) | Revenue Per Share | Quarterly Revenue Growth (0.05) | Return On Assets |
The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.